THVD-201

DRUG2 trials

Sponsors

TheraVida, Inc., SK Chemicals Co., Ltd.

Conditions

IncontinenceOveractive Bladder

Phase 1

Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects

CompletedNCT01036035

TheraVida, Inc.Incontinence

Start: 2009-09-30End: 2010-04-30Updated: 2015-12-30

Phase 3

Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB

CompletedNCT02485067

SK Chemicals Co., Ltd.Overactive Bladder

Start: 2015-01-31End: 2016-09-30Updated: 2017-01-12